Revvity, Inc. (NYSE:RVTY) Stake Lifted by Toronto Dominion Bank

Toronto Dominion Bank raised its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 40.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,374 shares of the company's stock after acquiring an additional 16,881 shares during the quarter. Toronto Dominion Bank's holdings in Revvity were worth $6,515,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Assetmark Inc. increased its holdings in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares during the last quarter. Optiver Holding B.V. acquired a new stake in shares of Revvity during the fourth quarter worth approximately $33,000. Quarry LP grew its position in shares of Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after buying an additional 95 shares in the last quarter. Millstone Evans Group LLC bought a new stake in shares of Revvity in the fourth quarter worth $38,000. Finally, Continuum Advisory LLC raised its holdings in Revvity by 39.3% in the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company's stock valued at $53,000 after acquiring an additional 133 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Analysts Set New Price Targets

Several research analysts have weighed in on RVTY shares. Barclays decreased their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. The Goldman Sachs Group decreased their price target on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Raymond James reaffirmed an "outperform" rating and set a $120.00 target price (down previously from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Finally, Wall Street Zen lowered Revvity from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Five investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Revvity currently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Stock Performance

RVTY stock traded up $1.17 during mid-day trading on Tuesday, reaching $90.49. The company had a trading volume of 145,788 shares, compared to its average volume of 949,229. Revvity, Inc. has a one year low of $87.92 and a one year high of $129.50. The stock has a market capitalization of $10.67 billion, a P/E ratio of 40.95, a P/E/G ratio of 3.82 and a beta of 1.02. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The stock's 50-day simple moving average is $94.66 and its two-hundred day simple moving average is $107.96.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. Revvity's quarterly revenue was up 2.3% compared to the same quarter last year. During the same period last year, the firm posted $0.98 EPS. Research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.31%. Revvity's dividend payout ratio (DPR) is presently 11.91%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.